Category: Pharmaceuticals
Pharmaceuticals market research reports by Plunkett Research, Ltd.
-
Financial Analysis and Multi-Year Benchmarking: Rohto Pharmaceutical Co Ltd (RPHCF:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Rohto Pharmaceutical Co Ltd (RPHCF:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings. This unique new report provides deep financial benchmarks for Rohto Pharmaceutical Co ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Sumitomo Dainippon Pharma Co Ltd (SMDPY:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Sumitomo Dainippon Pharma Co Ltd (SMDPY:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings. This unique new report provides deep financial benchmarks for Sumitomo Dainippon ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Alfresa Holdings Corp (ALFRY:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Alfresa Holdings Corp (ALFRY:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings. This unique new report provides deep financial benchmarks for Alfresa Holdings Corp (ALFRY:P ... Read More
-
Financial Analysis and Multi-Year Benchmarking: ASKA Pharmaceutical Holdings Co Ltd (ASKPF:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: ASKA Pharmaceutical Holdings Co Ltd (ASKPF:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings. This unique new report provides deep financial benchmarks for ASKA Pharmaceuti ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Kissei Pharmaceutical Co (KSPHF:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Kissei Pharmaceutical Co (KSPHF:PINX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Key Findings. This unique new report provides deep financial benchmarks for Kissei Pharmaceutical Co (K ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325414
Revenue Forecasts to (2031) and Analytics for the Vaccines, Skin Replacement Products and Biologicals Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325414 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save co ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325412
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals, Biopharmaceuticals, Generics and Drug Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325412 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325411
Revenue Forecasts to (2031) and Analytics for the Vitamins, Botanicals, Nutritional Supplements and Medicinal Chemicals Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325411 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals, Medicines, Supplements and Drug Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325400
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals, Medicines, Supplements and Drug Manufacturing (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 325400 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save count ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Health Practitioners Offices (except Physicians or Dentists), Chiropractors, Optometrists, Mental Health (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 621300
Revenue Forecasts to (2031) and Analytics for the Health Practitioners Offices (except Physicians or Dentists), Chiropractors, Optometrists, Mental Health (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 621300 Vital industry-specific data including metrics, benchmarks, historic numbers, growt ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Drug Stores and Pharmacies (Pharmacy), plus Nutrition, Beauty and Health Products Stores (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 446000
Revenue Forecasts to (2031) and Analytics for the Drug Stores and Pharmacies (Pharmacy), plus Nutrition, Beauty and Health Products Stores (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 446000 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and fore ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals and Druggists' Merchandise Distributors (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 424210
Revenue Forecasts to (2031) and Analytics for the Pharmaceuticals and Druggists' Merchandise Distributors (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 424210 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save countless ho ... Read More
-
Revenue Forecasts to (2031) and Analytics for the Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 424200
Revenue Forecasts to (2031) and Analytics for the Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors (U.S.): Financial Benchmarks, Metrics, P&L, KPIs, NAIC 424200 Vital industry-specific data including metrics, benchmarks, historic numbers, growth rates and forecasts that will save coun ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Kineta Inc (KA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Kineta Inc (KA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Kineta Inc (KA:NAS). Includes Industry Averages & Top Competitors, KPIs, ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Reata Pharmaceuticals (RETA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Reata Pharmaceuticals (RETA:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Reata Pharmaceuticals (RETA:NAS). Includes Industry Averages ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Eagle Pharmaceuticals Inc (EGRX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Eagle Pharmaceuticals Inc (EGRX:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Eagle Pharmaceuticals Inc (EGRX:NAS). Includes Industry ... Read More
-
Financial Analysis and Multi-Year Benchmarking: TRACON Pharmaceuticals Inc (TCON:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: TRACON Pharmaceuticals Inc (TCON:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: TRACON Pharmaceuticals Inc (TCON:NAS). Includes Industr ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Eupraxia Pharmaceuticals Inc (EPRX:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Eupraxia Pharmaceuticals Inc (EPRX:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Eupraxia Pharmaceuticals Inc (EPRX:TSE). Includes Ind ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Medexus Pharmaceuticals Inc (MDP:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Medexus Pharmaceuticals Inc (MDP:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Medexus Pharmaceuticals Inc (MDP:TSE). Includes Industr ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Waverley Pharma Inc (WAVE:TSX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Waverley Pharma Inc (WAVE:TSX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Waverley Pharma Inc (WAVE:TSX). Includes Industry Averages & T ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Aurinia Pharmaceuticals Inc (AUPH:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Aurinia Pharmaceuticals Inc (AUPH:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Aurinia Pharmaceuticals Inc (AUPH:NAS). Includes Indus ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Knight Therapeutics Inc (GUD:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Knight Therapeutics Inc (GUD:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Knight Therapeutics Inc (GUD:TSE). Includes Industry Averag ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Arbutus Biopharma Corp (ABUS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Arbutus Biopharma Corp (ABUS:NAS). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Arbutus Biopharma Corp (ABUS:NAS). Includes Industry Averag ... Read More
-
Financial Analysis and Multi-Year Benchmarking: HLS Therapeutics Inc (HLS:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: HLS Therapeutics Inc (HLS:TSE). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: HLS Therapeutics Inc (HLS:TSE). Includes Industry Averages & T ... Read More
-
Financial Analysis and Multi-Year Benchmarking: Aequus Pharmaceuticals Inc (AQS:TSX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts.
Financial Analysis and Multi-Year Benchmarking: Aequus Pharmaceuticals Inc (AQS:TSX). Includes Industry Averages & Top Competitors, KPIs, EBITDA, Income Statement. Market Size & Growth Forecasts. Financial Analysis and Multi-Year Benchmarking: Aequus Pharmaceuticals Inc (AQS:TSX). Includes Industry ... Read More
Research Assistance
